In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Sensus Healthcare Inc (NASDAQ: SRTS) closed at $6.07 up 4.03% from its previous closing price of $5.84. In other words, the price has increased by $4.03 from its previous closing price. On the day, 0.86 million shares were traded.
Ratios:
For a deeper understanding of Sensus Healthcare Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.51 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 47.60. For the most recent quarter (mrq), Quick Ratio is recorded 7.93 and its Current Ratio is at 9.64. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on January 31, 2025, initiated with a Buy rating and assigned the stock a target price of $18.
On November 15, 2024, Maxim Group reiterated its Buy rating and also lowered its target price recommendation from $12 to $14.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 10 ’25 when Rampolla Javier bought 501 shares for $5.95 per share. The transaction valued at 2,981 led to the insider holds 40,745 shares of the business.
Sardano Michael bought 1,000 shares of SRTS for $5,950 on Feb 10 ’25. The PRESIDENT AND GENERAL COUNSEL now owns 115,839 shares after completing the transaction at $5.95 per share. On May 20 ’24, another insider, Heinrich John, who serves as the Director of the company, sold 15,227 shares for $6.24 each. As a result, the insider received 95,016 and left with 59,940 shares of the company.
Valuation Measures:
As of this moment, Sensus’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.93, and their Forward P/E ratio for the next fiscal year is 8.77. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.38 while its Price-to-Book (P/B) ratio in mrq is 1.79.
Stock Price History:
Over the past 52 weeks, SRTS has reached a high of $9.33, while it has fallen to a 52-week low of $2.91. The 50-Day Moving Average of the stock is -18.82%, while the 200-Day Moving Average is calculated to be -4.53%.
Shares Statistics:
A total of 16.50M shares are outstanding, with a floating share count of 13.17M. Insiders hold about 19.62% of the company’s shares, while institutions hold 24.91% stake in the company.
